Articles tagged "Adverse effects"

2019 American Transplant Congress
Safety and Efficacy of Peri-Operative Sublingual Tacrolimus in Pancreas Transplant as Compared to Oral Tacrolimus
N. Patel, C. Perez, D. Taber, V. Kalbavi, V. Rohan
MUSC, Charleston, SC
*Purpose: Early post-transplant, use of oral or enteral medications in pancreas transplant (PTX) is difficult due to NG tubes put to suction. The use of…
2019 American Transplant Congress
Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation
S. Ries,¹, N. J. Skill¹, E. Campbell¹, R. Daniel², C. A. Kubal¹, M. S. Richard¹, M. A. Maluccio¹
¹Surgery, Indiana University, Indianapolis, IN, ²University of Washington, Seattle, WA
*Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…
2019 American Transplant Congress
Blockade of IL-1β and TNF-α Does Not Significantly Pose Risk or Affect Outcomes in Patients Infused with Microbial-Positive Autologous Islet Preparations
K. Kumano¹, C. Darden², S. Vasu¹, M. Lawrence¹, B. Naziruddin³, A. Gupta³, E. Beecherl³, N. Onaca³
¹Baylor Scott and White Research Institute, Dallas, TX, ²Baylor University, Waco, TX, ³Baylor Simmons Transplant Institute, Dallas, TX
*Purpose: We recently demonstrated that the combined use of anakinra (IL-1β blocker) and etanercept (TNF-α blocker) improved outcomes of islet autotransplantation after total pancreatectomy (TPIAT).…
2019 American Transplant Congress
Determinants of Allograft Injury during Procurement in Deceased Donors
E. Taber-Hight¹, R. Cauwels², E. Eidbo², A. S. Paramesh³, R. Squires⁴, T. Taber¹
¹Nephrology, Indiana University, Indianapolis, IN, ²AOPO, Vienna, VA, ³Louisiana Organ Procurement Agency, New Orleans, LA, ⁴University of Oklahoma, Oklahoma City, OK
*Purpose: With the ever enlarging list of potential recipients on the transplant list, the need for deceased donor organs has become critical. Avoiding injury to…
2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Transplant Recipients
T. Harrison¹, K. Foster¹, N. Patel¹, H. Meadows¹, C. Perez¹, H. Corbo¹, J. Fleming¹, N. Pilch¹, D. DuBay², J. McGillicuddy², S. Nadig², V. Rohan², D. Taber¹
¹Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss amongst all organ groups. It is unclear how medication side…
2019 American Transplant Congress
Hepatitis Flare in Hepatitis B Core Antibody Positive Kidney Recipients Treated with Rituximab
M. Raja¹, Y. Natori¹, C. Donato¹, D. De Lima¹, J. Rivollo², A. Centeno², Y. Ebisu¹, L. Abbo¹, J. Simkins¹, S. Anjan¹, J. Camargo¹, M. I. Morris¹
¹Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, ²Jackson Memorial Hospital, Miami, FL
*Purpose: Patients with Hepatitis B Core Antibody (anti-HBc Ab) positive are known to be at risk for Hepatitis B virus (HBV) reactivation during periods of…
2019 American Transplant Congress
Parental Anxiety and Depression Rates across Pediatric Solid Organ Transplant Populations
A. M. Lofton¹, A. Wille¹, E. A. Steinberg², C. Buchanan²
¹Psychiatry, Children's Hospital Colorado, Aurora, CO, ²Psychiatry, University of Colorado SOM, Children's Hospital Colorado, Aurora, CO
*Purpose: This study’s purpose is to examine parental self-report of depression and anxiety symptoms during the pre-transplant evaluation process for solid organ transplant pediatric candidates…
2019 American Transplant Congress
Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Lung Transplant in the United States
S. Riad¹, U. Goswami², S. Jackson³, M. Hertz²
¹Medicine, University of Minnesota, Eden Prairie, MN, ²Medicine, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction regimens for kidney transplant alone (KT) in lung recipients vary widely among transplant centers. We sought to examine the impact of kidney induction…
2019 American Transplant Congress
Correlation between Self-Reported Medication Adherence and Side Effects in Cardiothoracic Transplant Recipients
T. Harrison¹, N. Patel¹, H. Corbo¹, K. Foster¹, H. Meadows¹, N. Pilch¹, C. Perez¹, J. Fleming¹, D. Judge², L. Paoletti³, D. Taber¹
¹Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Cardiology, Medical University of South Carolina, Charleston, SC, ³Pulmonary & Critical Care Medicine, Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor for acute rejection and graft loss. It is unclear how medication side effects (SE) and perceived…
2019 American Transplant Congress
Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients
S. Hamel¹, V. Johnson², D. Johnson², E. Blumberg³, R. Bloom⁴, J. Trofe-Clark²
¹Pharmacy, Vanderbilt Univ. Medical Center, Nashville, TN, ²Pharmacy, Hospital of the Univ. of Pennsylvania, Philadelphia, PA, ³Infectious Diseases, Univ. of Pennsylvania, Philadelphia, PA, ⁴Renal, Univ. of Pennsylvania, Philadelphia, PA
*Purpose: Secondary options for Pneumocystis Jirovecii pneumonia (PJP) prophylaxis in kidney transplant recipients (KTRs) include atovaquone or dapsone. Atovaquone use may be limited by cost/side…

« Previous Page
1
…
8
9
10
11
12
…
18
Next Page »